SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-23-038555
Filing Date
2023-08-04
Accepted
2023-08-04 16:03:56
Documents
51
Period of Report
2023-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q prds-20230630.htm   iXBRL 10-Q 1813394
2 EX-31.1 prds-ex31_1.htm EX-31.1 21138
3 EX-31.2 prds-ex31_2.htm EX-31.2 21466
4 EX-32 prds-ex32.htm EX-32 21679
  Complete submission text file 0000950170-23-038555.txt   6023859

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT prds-20230630_lab.xml EX-101.LAB 305371
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT prds-20230630_cal.xml EX-101.CAL 26000
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT prds-20230630_pre.xml EX-101.PRE 221127
8 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT prds-20230630.xsd EX-101.SCH 33832
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT prds-20230630_def.xml EX-101.DEF 145754
45 EXTRACTED XBRL INSTANCE DOCUMENT prds-20230630_htm.xml XML 1056932
Mailing Address 2173 SALK AVENUE SUITE 250, PMB#052 CARLSBAD CA 92008
Business Address 2173 SALK AVENUE SUITE 250, PMB#052 CARLSBAD CA 92008 415-649-8758
PARDES BIOSCIENCES, INC. (Filer) CIK: 0001822711 (see all company filings)

IRS No.: 852696306 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40067 | Film No.: 231143955
SIC: 2834 Pharmaceutical Preparations